Vectura Group Share Price (VEC)

138.85 +1.95 (+1.42%) delayed: 9:34AM GMT
Bid price 138.70 Open price 137.30
Ask price 139.00 Prev close 136.90
High price 139.40 Spread 0.22%
Low price 137.30 Volume 265,206

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 138.85 Net Gearing (%) -17.92
Market Capitalisation (£m) 931.72 Gross Gearing (%) 17.01
Shares in issue (m) 677.61 Debt Ratio 8.28
P/E Ratio 114.58 Debt-to-Equity Ratio 0.44
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.21
Dividend Yield (%) 0.00 Price to book value 3.93
Dividend cover (x) 0.00 ROCE (%) -0.73
Earning per share (p) 1.20 EPS Growth (%) 33.33
52 week high / low 200.00 / 122.80 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
03/10/2016 BUY Susan Foden NED 6,500
30/09/2016 BUY Andrew Derodra FD 30,000
28/09/2016 EXR Dr Trevor Phillips ED 510,952
28/09/2016 SEXR Dr Trevor Phillips ED 240,841
27/09/2016 BUY Bruno Angelici CH 80,000

More Vectura Group Director Deals >>

Vectura Group Company News

07:05 08/12/2016

FLASH: Vectura updates on Ultibro Breezhaler

Story provided by

07:00 08/12/2016

Ultibro Breezhaler improved lung function

RNS Number : 2560R Vectura Group plc 08 December 2016       Ultibro® Breezhaler® improved lung function and COPD symptoms after direct switch from previous treatment   ·   Ultibro® Breezhaler® improved lung function and breathlessness after direct switch from...

07:00 01/12/2016

Total Voting Rights

RNS Number : 6321Q Vectura Group plc 01 December 2016   Vectura Group plc (the "Company") VOTING RIGHTS AND CAPITAL Chippenham, UK, 1 December 2016:   In accordance with the Financial Conduct Authority's Transparency Directive, Transitional Provision 6, Vectura Group...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

3 months ago


Powered by IST's

Register now for FREE Vectura Group share price discussions